Isracann Biosciences Inc (ISCNF)
0.00
USD |
OTCM |
Apr 17, 16:00
Isracann Biosciences Shareholders Equity (Quarterly): 0.0979M for Aug. 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | 0.0979M |
| May 31, 2022 | 0.232M |
| February 28, 2022 | 1.596M |
| November 30, 2021 | 2.074M |
| August 31, 2021 | 2.752M |
| May 31, 2021 | 3.260M |
| February 28, 2021 | 19.38M |
| November 30, 2020 | 18.83M |
| August 31, 2020 | 19.73M |
| May 31, 2020 | 19.15M |
| February 29, 2020 | 35.95M |
| November 30, 2019 | 38.54M |
| August 31, 2019 | 10.76M |
| May 31, 2019 | 11.34M |
| February 28, 2019 | 8.38M |
| November 30, 2018 | 4.618M |
| August 31, 2018 | 7.019M |
| May 31, 2018 | 10.59M |
| February 28, 2018 | 11.82M |
| November 30, 2017 | 4.294M |
| August 31, 2017 | -0.0441M |
| May 31, 2017 | 0.0609M |
| February 28, 2017 | 0.1592M |
| November 30, 2016 | 0.175M |
| Date | Value |
|---|---|
| August 31, 2016 | 0.2934M |
| May 31, 2016 | 0.4604M |
| February 29, 2016 | 0.5373M |
| August 31, 2015 | 0.7126M |
| May 31, 2015 | 0.8434M |
| February 28, 2015 | 0.8676M |
| November 30, 2014 | 1.039M |
| August 31, 2014 | 1.222M |
| May 31, 2014 | 0.1255M |
| February 28, 2014 | 0.1622M |
| November 30, 2013 | 0.1845M |
| August 31, 2013 | 0.2069M |
| May 31, 2013 | 0.2312M |
| February 28, 2013 | 0.2584M |
| November 30, 2012 | 0.2824M |
| August 31, 2012 | 0.2685M |
| May 31, 2012 | 0.2946M |
| February 29, 2012 | 0.3295M |
| November 30, 2011 | 0.3326M |
| August 31, 2011 | 0.3794M |
| May 31, 2011 | 0.3843M |
| February 28, 2011 | 0.4091M |
| November 30, 2010 | 0.4209M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.0979M
Minimum
Aug 2022
38.54M
Maximum
Nov 2019
13.12M
Average
11.05M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.085M |
| Total Liabilities (Quarterly) | 2.990M |